Zhang W T, Liu D, Xie C J, Shen D, Chen Z Q, Li Z H, Liu Y, Zhang X R, Chen P L, Zhong W F, Yang P, Huang Q M, Luo L, Mao C
Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China.
Guangzhou Municipal Center for Disease Control and Prevention, Guangzhou 511430, China.
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Aug 10;42(8):1347-1352. doi: 10.3760/cma.j.cn112338-20201211-01400.
To analyze the sensitivity and specificity of SARS-CoV-2 nucleic acid testing in 20 348 close contacts of COVID-19 cases in different prevention and control stages in Guangzhou and to provide scientific evidence for optimizing epidemic response strategies. A total of 20 348 close contacts of COVID-19 cases in Guangzhou were traced between February 21 and September 22,2020. All the close contacts were tested for the nucleic acid of SARS-CoV-2. The sensitivity and specificity of nucleic acid testing and diagnosis in the different prevention and control stages were compared. In 20 348 close contacts, 12 462 were males (61.24%), the median (,) of age of them was 31.0 years (23.0,43.0), the median number (,) of nucleic acid testing for them was 2.0 (1.0,3.0), and the median (,) of their quarantine days was 12.0 (8.0,13.0) days, respectively. A total of 256 COVID-19 cases were confirmed in the close contacts after seven nucleic acid tests. In the 1, 2, 3 and 7 nucleic acid testing, the sensitivity and specificity were 69.14% and 99.99% (177 cases confirmed), 89.84% and 99.99% (230 cases confirmed), 97.27% and 99.99% (249 cases confirmed), and 100.00% and 99.98%, respectively. In the three stages of COVID-19 prevention and control in China: domestic case stage, imported case stage, and imported case associated local epidemic stage, the sensitivity of the 1 nucleic acid testing was 70.68%, 68.00% and 67.35%, and the specificity was 99.98%, 100.00% and 100.00%, respectively. The sensitivity of nucleic acid testing in the close contacts at the different stages were consistent with slight decrease, which might be related to the increased proportion of asymptomatic infections in the late stage of epidemic prevention and control with COVID-19 in Guangzhou. It is suggested to give three nucleic acid tests to improve the sensitivity and reduce false negative risk.
分析广州市不同防控阶段20348例新冠肺炎病例密切接触者中新型冠状病毒2019核酸检测的敏感性和特异性,为优化疫情应对策略提供科学依据。2020年2月21日至9月22日期间,共追踪了广州市20348例新冠肺炎病例密切接触者。对所有密切接触者进行新型冠状病毒2019核酸检测,比较不同防控阶段核酸检测及诊断的敏感性和特异性。在20348例密切接触者中,男性12462例(61.24%),年龄中位数为31.0岁(23.0,43.0),核酸检测次数中位数为2.0次(1.0,3.0),隔离天数中位数为12.0天(8.0,13.0)。经过7次核酸检测,密切接触者中共确诊256例新冠肺炎病例。在第1、2、3和7次核酸检测中,敏感性和特异性分别为69.14%和99.99%(确诊177例)、89.84%和99.99%(确诊230例)、97.27%和99.99%(确诊249例)、100.00%和99.98%。在中国新冠肺炎防控的三个阶段:本土病例阶段、输入病例阶段和输入病例关联本土疫情阶段,第1次核酸检测的敏感性分别为70.68%、68.00%和67.35%,特异性分别为99.98%、100.00%和100.00%。不同阶段密切接触者核酸检测的敏感性呈轻微下降趋势且具有一致性,这可能与广州新冠肺炎疫情防控后期无症状感染者比例增加有关。建议进行3次核酸检测以提高敏感性并降低假阴性风险。